跳至主要内容
临床试验/NL-OMON44830
NL-OMON44830已完成不适用

Prevalence of gastrointestinal disorders in the general population 50 to 75 years in the Ommoord municipality: videocapsule in the Rotterdam study - Videocapsule-ERGO

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 1,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - 50-74 years
  • - participant Rotterdam study

排除标准

  • - Inability or refusal to provide informed consent.
  • - Persons with a severe or terminal disease with a life-expectancy of less than 5 years.
  • - An allergy or any other known contraindication to the medication used in this study
  • - Renal failure, eGFR <30 ml/min/1.73m2
  • - Congestive heart failure NYHA class III or IV
  • - Dysphagia or other swallowing disorder which makes it impossible to swallow the capsule.
  • - High risk of capsule retention: IBD, Personal history of gastrointestinal surgery other than uncomplicated procedures that would be unlikely to lead to bowel obstruction based on the clinical judgment of the investigator.
  • - Cardiac pacemakers or other implanted electro-medical equipment.
  • - An MRI scheduled within 14 days after ingestion of the capsule.
  • - Patients with diagnosed or suspected Congenital Long QT Syndrome
  • - Patients with concomitant use of drugs that prolong the QT interval

研究者

相似试验

Prevalence of gastrointestinal disorders in the... | 临床试验